Article
Multiple endpoints for somatic mutations in humans provide complementary views for biodosimetry, genotoxicity and health risks.
Progress in clinical and biological research - 1 Jan 1990
Jensen R H, Bigbee W L, Langlois R G
Abstract excerpt
While monitoring people with multi-endpoint analysis is only just beginning, the indications of complementarity of these assays are already evident. Since two different tissue types are analyzed, effects of uneven exposure or tissue-specific sensitivities or development kinetics and persistence of each cell type can be addressed. The differing analytical techniques in determining variant cells lead to particular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.